Clinical Trials Directory

Trials / Unknown

UnknownNCT03554148

Bacteria and Intestinal Translocation in Surgery (Bandit)

Assessment of Bacterial Translocation on the Incidence of Surgical Site Infection in Abdominal Surgery: Prospective Cohort Study.

Status
Unknown
Phase
Study type
Observational
Enrollment
209 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Patients undergoing elective abdominal surgery will be included prospectively. Informed consent will be obtained. Preoperatively baseline health data is collected and a skin swab and rectal swab for baseline skin and gut microbiota is taken. During the surgery additional clinical data and additional samples will be obtained. Additional samples include: rectal swab, biopsies of the resected specimen (lymph node, peritoneum, intestinal content, mucosa), venous blood sample (7.5ml) at the end of the operation, liver biopsy and skin biopsy. Postoperative health data is recorded. If a surgical site infection occurs a swab is taken too. With 16 sRNA (small ribonucleic acid) based sequencing the investigators will quantify the abundance of the different bacterial species in all samples. Primary outcome will be to assess a difference of 16sRNA signal in the liver and lymph node biopsies between patients with and patients without surgical site infection. Secondary outcomes include variables predicting the occurence of surgical site infections and a model describing the way bacteria may take to cause wound infection.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThis is purely an observational study. Groups SSI/No SSI are defined by the occurence of a surgical site infection.

Timeline

Start date
2017-07-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2018-06-12
Last updated
2022-05-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03554148. Inclusion in this directory is not an endorsement.